Bioceres Crop Solutions Corp. (NASDAQ:BIOX – Get Free Report) was the target of a significant decline in short interest during the month of July. As of July 31st, there was short interest totalling 386,700 shares, a decline of 21.5% from the July 15th total of 492,300 shares. Currently, 1.3% of the shares of the company are sold short. Based on an average daily trading volume, of 58,300 shares, the days-to-cover ratio is currently 6.6 days.
Institutional Trading of Bioceres Crop Solutions
Institutional investors and hedge funds have recently made changes to their positions in the company. Fourth Sail Capital LP raised its position in shares of Bioceres Crop Solutions by 136.1% during the first quarter. Fourth Sail Capital LP now owns 1,627,630 shares of the company’s stock worth $20,606,000 after acquiring an additional 938,282 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. boosted its holdings in Bioceres Crop Solutions by 46.7% in the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 136,635 shares of the company’s stock worth $1,876,000 after buying an additional 43,484 shares during the period. Oppenheimer & Co. Inc. purchased a new position in shares of Bioceres Crop Solutions during the 1st quarter valued at $139,000. Wellington Management Group LLP boosted its holdings in shares of Bioceres Crop Solutions by 3.1% in the 4th quarter. Wellington Management Group LLP now owns 236,906 shares of the company’s stock worth $3,253,000 after purchasing an additional 7,096 shares in the last quarter. Finally, Lazard Asset Management LLC purchased a new stake in shares of Bioceres Crop Solutions during the first quarter valued at approximately $212,000. Institutional investors own 17.68% of the company’s stock.
Analysts Set New Price Targets
A number of research analysts have recently commented on BIOX shares. Canaccord Genuity Group reaffirmed a “buy” rating and set a $17.00 price objective on shares of Bioceres Crop Solutions in a research report on Friday, July 19th. Roth Capital upgraded shares of Bioceres Crop Solutions to a “strong-buy” rating in a research note on Tuesday, July 2nd. Canaccord Genuity Group upgraded Bioceres Crop Solutions to a “strong-buy” rating in a research note on Friday, July 19th. Finally, Roth Mkm began coverage on shares of Bioceres Crop Solutions in a research report on Tuesday, July 2nd. They issued a “buy” rating and a $15.00 price target on the stock. Three investment analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat.com, Bioceres Crop Solutions has an average rating of “Buy” and a consensus price target of $19.00.
Bioceres Crop Solutions Trading Up 0.9 %
Shares of BIOX stock traded up $0.09 on Thursday, reaching $10.16. The company had a trading volume of 13,971 shares, compared to its average volume of 57,594. The company has a 50-day moving average of $10.80 and a 200-day moving average of $11.89. Bioceres Crop Solutions has a 12 month low of $9.71 and a 12 month high of $14.05. The stock has a market cap of $638.02 million, a PE ratio of 1,007.00 and a beta of 0.50. The company has a current ratio of 1.22, a quick ratio of 0.83 and a debt-to-equity ratio of 0.29.
Bioceres Crop Solutions (NASDAQ:BIOX – Get Free Report) last issued its quarterly earnings results on Wednesday, May 29th. The company reported $0.14 earnings per share for the quarter, missing the consensus estimate of $0.16 by ($0.02). Bioceres Crop Solutions had a return on equity of 0.28% and a net margin of 0.21%. The business had revenue of $83.98 million for the quarter, compared to the consensus estimate of $88.80 million. On average, equities analysts forecast that Bioceres Crop Solutions will post 0.35 earnings per share for the current year.
About Bioceres Crop Solutions
Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.
Featured Articles
- Five stocks we like better than Bioceres Crop Solutions
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Michael Burry’s Alibaba Bet and the Broader Market Implications
- Market Cap Calculator: How to Calculate Market Cap
- Jeff Brown’s Exegesis AI Stock Picks
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Warren Buffett’s Bet: Why Berkshire Hathaway Bought Ulta Stock
Receive News & Ratings for Bioceres Crop Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioceres Crop Solutions and related companies with MarketBeat.com's FREE daily email newsletter.